Cargando…
Cost-effectiveness of the tubeless automated insulin delivery system vs standard of care in the management of type 1 diabetes in the United States
BACKGROUND: A tubeless, on-body automated insulin delivery (AID) system (Omnipod 5 Automated Insulin Delivery System) demonstrated improved glycated hemoglobin A1c levels and increased time in range (70 mg/dL to 180 mg/dL) for both adults and children with type 1 diabetes in a 13-week multicenter, s...
Autores principales: | Biskupiak, Joseph E, Ramos, Mafalda, Levy, Carol J, Forlenza, Greg, Hopley, Colin, Boyd, Jennifer, Swift, Dan, Lamotte, Mark, Brixner, Diana I |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Academy of Managed Care Pharmacy
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10394185/ https://www.ncbi.nlm.nih.gov/pubmed/37133431 http://dx.doi.org/10.18553/jmcp.2023.22331 |
Ejemplares similares
-
First Outpatient Evaluation of a Tubeless Automated Insulin Delivery System with Customizable Glucose Targets in Children and Adults with Type 1 Diabetes
por: Forlenza, Gregory P., et al.
Publicado: (2021) -
Multicenter Trial of a Tubeless, On-Body Automated Insulin Delivery System With Customizable Glycemic Targets in Pediatric and Adult Participants With Type 1 Diabetes
por: Brown, Sue A., et al.
Publicado: (2021) -
Cost Implications of Formulary Decisions on Oral Anticoagulants in Nonvalvular Atrial Fibrillation
por: Biskupiak, Joseph, et al.
Publicado: (2013) -
Percutaneous nephrolithotomy: Large tube, small tube, tubeless, or totally tubeless?
por: Agrawal, Madhu S, et al.
Publicado: (2013) -
Comparative Study between Standard and Totally Tubeless Percutaneous Nephrolithotomy
por: Yun, Sung Il, et al.
Publicado: (2012)